Skip to content

Nicox SA completes purchase of Aciex Therapeutics, Inc. following shareholder approval of over 97%

Nicox S.A. (NYSE Euronext Paris: COX), a company focused on the ophthalmology medicines market has announced the approval by its shareholders for the acquisition of Aciex Therapeutics, Inc., a US-based, ophthalmic development company with lead programs in conjunctivitis and post-operative ocular inflammation. The transaction is understood to be scheduled for completion within a number of days.